Neurogene
NGNE
NGNE
52 hedge funds and large institutions have $253M invested in Neurogene in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+9
Holders Change %
+20.93%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
16
Reduced
9
Closed
6
Calls
$208K
Puts
$127K
Net Calls
+$81K
Net Calls Change
+$477K
Top Buyers
Top Sellers
1 |
BlackRock
New York
|
$11.9M |
2 |
Goldman Sachs
New York
|
$9.54M |
3 |
VEA
Virtus ETF Advisers
New York
|
$0 |
4 |
AP
Archon Partners
Princeton Junction,
New Jersey
|
$0 |
5 |
ProShare Advisors
Bethesda,
Maryland
|
$0 |